Human Albumin 25% in Medical Diseases

Established Indications with Strong Evidence

The American Association for the Study of Liver Diseases (AASLD) recommends administering 8 g of albumin per liter of ascites removed after large-volume paracentesis (>5L) to prevent paracentesis-induced circulatory dysfunction and reduce hyponatremia 1, 2
In patients with spontaneous bacterial peritonitis (SBP), give 1.5 g/kg within 6 hours of diagnosis, followed by 1.0 g/kg on day 3, to reduce acute kidney injury and mortality 1, 2
For hepatorenal syndrome (HRS-AKI), administer 1 g/kg on day 1, then 20-40 g daily in combination with vasoconstrictors, until serum creatinine returns to within 0.3 mg/dL of baseline for 2 consecutive days, or maximum 14 days 1, 3
In severe burns (>30% Total Body Surface Area), administer albumin after the first 6 hours of management, targeting plasma albumin concentration of 2.5 ±0.5 g/100 mL or plasma oncotic pressure of 20 mmHg 4

The FDA label explicitly states that albumin is NOT justified for stabilized hypoproteinemia accompanying chronic cirrhosis, chronic nephrosis, protein-losing enteropathy, malabsorption, and pancreatic insufficiency, or for intravenous nutrition 5, 3
The AASLD guidelines confirm that targeting albumin >30 g/L in hospitalized cirrhotic patients showed no difference in infections, renal failure, or death, and was associated with higher rates of pulmonary edema and fluid overload 1, 5

Doses exceeding 87.5 g (>4×100 mL of 20% albumin) may worsen outcomes due to fluid overload 2, 5
High-risk scenarios for pulmonary complications include patients with cirrhosis receiving albumin infusions, traumatic brain injury patients, and ARDS patients with increased capillary permeability 6, 5

Albumin has a transient effect lasting hours to days, not weeks, and long-term administration requires weekly or twice-weekly dosing to maintain benefit 5, 2

Administering albumin to "correct" a low albumin number without addressing the underlying cause (inflammation, malnutrition, protein loss) 3
Assuming hypoalbuminemia equals malnutrition when inflammation is often the primary driver 3
Using albumin for chronic conditions like nephrotic syndrome or stable cirrhosis without acute complications 3
Rapid or excessive administration leading to fluid overload, especially in cirrhotic patients 1, 2
Ignoring the high cost (~$130 per 25g) when crystalloids would be equally effective 3, 5

Albumin should be infused slowly to avoid cardiac overload and prevent rapid‑onset pulmonary edema and volume overload, especially in patients with pre‑existing cardiomyopathy, cirrhosis, renal insufficiency, or advanced age. 7 (expert opinion)
A slow infusion permits gradual equilibration between the intravascular and interstitial compartments, reducing the risk of abrupt intravascular volume expansion. 7 (expert opinion)

Cirrhotic individuals are especially prone to volume‑overload complications because their altered hemodynamics and possible cirrhotic cardiomyopathy limit cardiac compensatory capacity; rapid albumin infusion can precipitate pulmonary edema. 7 (expert opinion)
Pre‑existing cirrhotic cardiomyopathy further heightens vulnerability to rapid intravascular volume expansion, making careful, slow infusion essential. 7 (expert opinion)

Patients with limited cardiac reserve—such as those with cardiac dysfunction, renal insufficiency, or the elderly—may have their compensatory mechanisms overwhelmed by rapid albumin administration, leading to pulmonary edema. 7 (expert opinion)